US2023355181A1PendingUtilityA1

Measurement device

83
Assignee: PHC HOLDINGS CORPPriority: Nov 4, 2008Filed: Jul 17, 2023Published: Nov 9, 2023
Est. expiryNov 4, 2028(~2.3 yrs left)· nominal 20-yr term from priority
A61B 5/721A61B 5/0004A61B 5/14532A61B 5/1486A61B 5/14865A61B 5/416A61B 5/4839A61B 5/4866A61B 5/681A61B 5/74A61M 5/14244A61M 5/1723G01N 27/3273A61B 5/11G01N 27/416A61B 2560/0406A61B 2562/0219A61B 2562/0295A61M 2005/1726A61M 2205/3368A61M 2205/502A61M 2230/201A61M 2230/50A61M 2230/63A61M 5/142G01N 27/327A61B 5/4806A61B 5/1116A61M 2205/582
83
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An insulin infusion device includes a cannula for infusing insulin under the skin and an insulin infusion section for storing therein insulin to be delivered to the cannula. The insulin infusion device also includes a motion measurement section that measures the tilt angle or rotation angle of a center axis of the insulin infusion section from a neutral position thereof, or vibration applied to the insulin infusion section, to output a measured value as motion information of living activity. The insulin infusion device also includes a controlling section that controls, based on the motion information, a process of notifying a user of the timing or recommended direction of priming of the insulin infusion section.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . An insulin infusion device comprising:
 a cannula for infusing insulin under the skin;   an insulin infusion section for storing therein insulin to be delivered to the cannula;   a motion measurement section that measures the tilt angle or rotation angle of a center axis of the insulin infusion section from a neutral position thereof, or vibration applied to the insulin infusion section, to output a measured value as motion information of living activity; and   a controlling section that controls, based on the motion information, a process of notifying a user of the timing or recommended direction of priming of the insulin infusion section.   
     
     
         2 . The insulin infusion device according to  claim 1 , further comprising a recording section that records therein the motion information. 
     
     
         3 . The insulin infusion device according to  claim 2 , further comprising a communication section that transmits the motion information recorded in the recording section. 
     
     
         4 . The insulin infusion device according to  claim 2 , further comprising a display section that displays thereon the motion information recorded in the recording section. 
     
     
         5 . The insulin infusion device according to  claim 1 , further comprising:
 a biosensor which selectively responds to a specific analyte in a biological fluid for detecting the presence or concentration of the analyte in the biological fluid;   an analyte measurement section that measures a characteristic amount of the analyte with the biosensor; and   a recording section that records therein the motion information and the characteristic amount with the motion information and the characteristic amount associated with each other.   
     
     
         6 . The insulin infusion device according to  claim 5 , wherein the biosensor is a continuous glucose monitoring sensor to be inserted under the skin. 
     
     
         7 . The insulin infusion device according to  claim 5 , wherein the biosensor is a blood glucose sensor for measuring blood glucose level. 
     
     
         8 . The insulin infusion device according to  claim 1 , further comprising a pump section for delivering insulin stored in the insulin infusion section to the cannula, 
 wherein the controlling section estimates, based the operation time of the pump section, the quantity of insulin being delivered by continuous subcutaneous insulin infusion or the quantity of the last bolus that is still active in the body (insulin on board), and records the estimated quantity in the recording section.   
     
     
         9 . The insulin infusion device according to  claim 1 , further comprising a living activity calculation section that calculates, based on the motion information, living activity level in terms of METs.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.